(Q46736732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Second primary melanomas on treatment with vemurafenib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

N Poulalhon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Debarbieux

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Thomas

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

27 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

887-888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities.

10 March 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJD.12093

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJD.12093

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJD.12093

21 January 2018

Identifiers

DOI

10.1111/BJD.12093

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23066856%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference